Equities

Hoshi Iryo-Sanki Co Ltd

7634:TYO

Hoshi Iryo-Sanki Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)4,325.00
  • Today's Change-25.00 / -0.57%
  • Shares traded700.00
  • 1 Year change+11.90%
  • Beta0.3105
Data delayed at least 20 minutes, as of Nov 15 2024 06:16 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Hoshi Iryo-Sanki Co Ltd grew revenues 7.25% from 13.78bn to 14.78bn while net income improved 12.01% from 1.25bn to 1.40bn.
Gross margin48.16%
Net profit margin8.79%
Operating margin12.17%
Return on assets4.43%
Return on equity5.87%
Return on investment5.49%
More ▼

Cash flow in JPYView more

In 2024, Hoshi Iryo-Sanki Co Ltd increased its cash reserves by 8.50%, or 764.27m. The company earned 2.41bn from its operations for a Cash Flow Margin of 16.32%. In addition the company used 744.85m on investing activities and also paid 902.91m in financing cash flows.
Cash flow per share396.07
Price/Cash flow per share11.98
Book value per share5,697.90
Tangible book value per share5,644.09
More ▼

Balance sheet in JPYView more

Hoshi Iryo-Sanki Co Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio3.15
Quick ratio3.08
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in JPY

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items increased 11.84%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)1.27%
Div growth rate (5 year)8.45%
Payout ratio (TTM)10.96%
EPS growth(5 years)11.33
EPS (TTM) vs
TTM 1 year ago
-24.27
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.